Study results suggest prostate cancer classification of ‘very low risk’ may no longer be necessaryMarch 13th 2023
"We think this is an important call to action for the NCCN to follow in the footsteps of the AUA, who recently removed VLR from its prostate cancer guidelines in its most recent update," says Kevin Shee, MD, PhD.
Prostate cancer disparities observed in American Indian/Alaskan Native patientsMarch 6th 2023
"[Although] American Indian/Alaskan Native patients do present with more advanced prostate cancer, show lower rates of definitive treatment, and higher mortality, once we adjust for some of these disparities in access, we found that there were no significant differences in mortality," says Carissa E. Chu, MD.
Expert discusses what is on the horizon for stone disease in coming yearsJanuary 3rd 2023
“As people think about how we can do stone surgery more effectively, less morbidly for our patients, and less invasively, I think we're going to see robots enter our picture,” says Thomas Chi, MD.
2022 recap: Dr. Chi highlights milestones in stone diseaseDecember 30th 2022
“We've got a lot of movement in terms of understanding how stones form, some pharmaceutical interventions that we can use to prevent stones, and then how we can get even less invasive to try to get stones in the least morbid way for our patients,” says Thomas Chi, MD.
Machine-learning algorithm for predicting stone recurrence shows promiseDecember 6th 2022
“We were able to develop a machine learning model that had decent accuracy…in predicting which patients would have an additional stone event and which patients wouldn't,” says Kevin Shee, MD, PhD.
UCSF Department of Urology Grand Rounds with Dr. Ezekiel J. Emanuel: October 14October 6th 2022
Join the discussion on Health Reform with world leader in health policy and bioethics, Ezekiel J. Emanuel, MD, PhD, the Vice Provost for Global Initiatives and expert panelists and UCSF leaders.
UCSF investigators improve MR-guided TRUS fusion biopsy for prostate cancer detection using HP 13C MRIOctober 4th 2022
"HP 13C MRI provides a quick five-minute, non-radioactive, metabolic imaging add-on exam to standard-of-care MRI that, in conjunction with guided biopsies, has great potential to improve the care of prostate cancer patients,” said Robert Bok, MD, PhD.
Dr. Anne Suskind on study of surgery for bladder/bowel dysfunction in older adultsSeptember 19th 2022
“We wanted to compare outcomes between nursing home residents and community-dwelling older adults undergoing surgery for bladder and bowel dysfunction,” explains Anne M. Suskind, MD.
UCSF prostate cancer specialist inducted into annual class of Giants of Cancer CareJune 21st 2022
Eric J. Small, MD, has been announced as one of the winners of the 10th annual Giants of Cancer Care awards. Small is being recognized for his achievements in the clinical practice and research of genitourinary cancers.
Destigmatizing Urology: Dr. Pruthi discusses mental healthMay 23rd 2022
“I think we often encourage our patients to share concerns about depression, anxiety, and other mental health conditions, yet are less likely ourselves to seek help due to this issue of stigma,” says Raj S. Pruthi, MD, MHA, FACS.
Apalutamide yields deep PSA response, improved patient-related end pointsFebruary 18th 2022
“Not only does a deep PSA response identify patients who will have improved survival and progression-free outcomes, but also it is also associated with maintenance of health-related quality of life, improved patient reported physical wellbeing, and a reduced risk of worsening pain and fatigue intensity,” said Eric Jay Small, MD.
PSMA-PET imaging may miss small pelvic nodal metastases in men with prostate cancerOctober 19th 2021
"Clinicians taking care of patients with high-risk prostate cancer being assessed for prostatectomy can use a positive [PSMA] PET scan as a true positive, whereas a negative scan cannot be used to exclude disease or inform nodal dissection," wrote Joseph Osborne, MD, PhD, and colleagues.
White paper addresses ethical considerations for older patients with incontinenceOctober 15th 2021
"As a committee, we felt that there was a need to put together a document to help field some of the ethical considerations that we run into in clinical care but have very little guidance on," says Anne M. Suskind, MD, MS, FACS, FPMRS.
Dr. Suskind overviews new white paper focused on incontinence in older patientsOctober 11th 2021
As a committee, we felt that there was a need to put together a document to help field some of the ethical considerations that we run into in clinical care but have very little guidance on,” says Anne M. Suskind, MD, MS, FACS, FPMRS.
Understanding patterns in prostate genomic testing using SEER and GPS assayOctober 4th 2021
In a recent study presented at the 2021 AUA Annual Meeting, Scarlett Gomez, MPH, PhD, and co-authors investigated the determinants of selecting active surveillance/watchful waiting as a treatment path for patients with localized, low-risk prostate cancer.